Latest News

 Filter by Provider

It's worth reviewing these before you make any changes to your Medicare coverage for next year.

Many seniors focus on the COLA, but there's another increase that will make a bigger difference for their finances.

XLU bounced off a 52-week low near $39 as rising Treasury yields pressured utilities; NextEra Energy and Southern Company, its top holdings, show signs of a sector bottom forming.

Meta could disappoint some investors with its outlook, but long-term investors should pay attention.

The S&P 500 is trading at valuation levels last seen before the dot-com bubble, with a disconnect between new highs and new lows.

One of the largest Social Security raises of the last 35 years has a dark side.

Rocket Companies is becoming a real-estate powerhouse, and its shares seem undervalued.

AI-driven demand is lifting earnings estimates and price targets across cybersecurity, semiconductor, and CPU stocks, including PANW, MRVL, AMD, and INTC, ahead of Q3 results.

Bear markets aren't reasons to panic -- they're opportunities to buy stocks "on sale."

Four nuclear reactor stocks could look very different by 2031, as progress in reactors, revenue growth, and valuations determine shareholder returns.

Nvidia will have a monster comeback in 2027.

Space industry experts see this business growing 18% annually over the next five years. Here's what that implies for space stock valuations.

SanDisk shares have surged 575% in 2026 on AI storage demand, and analysts including Mizuho, Rosenblatt, and Arete Research keep raising price targets ahead of earnings later this month.

The new massive media conglomerate has a lot to prove.

SpaceX looks poised to outperform Micron in the coming years.

Could Oklo be the first nuclear company to join the trillion-dollar club?

SpaceX is already racking up debt just four months after its IPO.

This company is positioned for medium-term and long-term growth in the AI market.

The warehouse club giant's share price has more than doubled in five years, with quarterly payouts adding a small sum to the returns.

Store brands are gaining unit share over national labels like McCormick as shoppers seek value, while Kroger and Walmart expand private-label lines to capture margin growth.

Netflix stock looks incredibly cheap heading into its third-quarter earnings report.

Tech and AI have dominated the past several years. The next couple of decades could look a lot different.

Two major forces could drive Marvell's earnings much higher.

When things seem too good to be true for the stock market, they usually are.

One of these coins has a fit with its market, and the other hasn't yet found one.

Its worst calendar year since 2012 was a loss of around 5.5%. What has that steadiness cost in the good years?

ASML is thinking years ahead of the AI industry, ensuring it remains an industry leader well into the 2030s.

Just because a solution isn't jaw-droppingly futuristic doesn't mean it's not incredibly marketable.

All eyes will be on the bellwether of the semiconductor sector.

The leading cruise line operator posted all-time-high metrics across the board in Q3.

These three coins are positioned to be valuable crypto infrastructure, and they're all gaining traction.

The fee gap starts at $37 a year. Where does it land after three decades?

Investors are eager to get exposure to certain private companies, and Cathie Wood is offering them a way to do that.

The company has raised its annual dividend for 13 consecutive years.

The robotaxi leader's just halfway to its year-end target. Does the stock need it to get there?

The weight-loss drugs are growing in popularity and altering consumer behavior in significant ways.

Micron has already surged 1,100% in a year and a half.

With investors nibbling at Solana ETFs, the Bitwise Solana Staking ETF could be a fund to consider heading into 2027.

A super-high yield isn't everything.

Buffett's investing rule is simple in some ways, but complicated in others.

Past dips in the warehouse club's shares have mostly paid off. Does a better September make this one worth buying?

FDA approval will help, as will insurer adoption of Galleri, but the price that they might be willing to pay for the test is also critical.

Things don’t always work out in the real world as they’re drawn up on paper.

If it grows at the rate it's grown over the past three years, your stake could end up worth over $400,000! (But closer to $38,000 is more likely.)

It's a big week for seniors. Here's what to gear up for.

The AI chip giant won't report for weeks. What can its chipmaker's results show investors first?

The people who hold Bitcoin have something that deep-pocketed buyers want.

PJP's one-year return beats RSPH's, but RSPH offers broader diversification across 61 healthcare holdings at a lower expense ratio.

This under-the-radar hospitality stock boasts a Superscore of 79 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

In case you forgot, the current CEO of Starbucks is the former CEO of Chipotle.